Halol

Why a Credit Suisse note has made Sun Pharma shoot up 6% in trade today

Sun Pharmaceutical Industries gained more than 6 percent today, heading towards its biggest single-day gain since April 9 after brokerage Credit Suisse said the pharma major has received a Form 483 from the US FDA on a Gujarat facility.<br />

Sun Pharma stock plummets: 5 reasons why it is getting hammered by investors

Majority of ex-Taro products of Sun Pharma for the US market come from the Halol facility